Sep 14, 2017
BEVERLY, MA--(Marketwired - September 14, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today confirmed enrollment of the first patient in the Company's mid-stage (Phase 2a) cl...
Aug 29, 2017
BEVERLY, MA--(Marketwired - August 29, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today reported financial results for the fiscal year ended June 30, 2017, and summarized the...
Jul 26, 2017
BEVERLY, MA--(Marketwired - July 26, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, announced today the filing of an application in Japan for patent coverage of the Company's new...